Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells

European Journal of Cell Biology

Volumn 90, Issue 8, 2011, Pages 642-648

  Wang, Yingyi ^a   Yan, Wei ^a   Lu, Xiaoming ^a   Qian, Chunfa ^b   Zhang, Junxia ^a   Li, Ping ^a   Shi, Lei ^c   Zhao, Peng ^a   Fu, Zhen ^a   Pu, Peiyu ^d   Kang, Chunshen ^d   Jiang, Tao ^e   Liu, Ning ^a   You, Yongping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c KUNSHAN FIRST PEOPLE S HOSPITAL AFFILIATED TO JIANGSU UNIVERSITY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Glioma; Osteopontin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHROMONES; ENDOTHELIAL CELLS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLIOMA; HUMANS; INTEGRIN ALPHAVBETA3; MEMBRANE PROTEINS; MORPHOLINES; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 79957688472     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.03.005     Document Type: Article

References (24)

1. Abid M.R., Guo S., Minami T., Spokes K.C., Ueki K., Skurk C., Walsh K., Aird W.C. Vascular endothelial growth factor activates PI3K/AKT/forkhead signaling in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2004, 24:294-300.
2. Ahn J.B., Rha S.Y., Shin S.J., Jeung H.C., Kim T.S., Zhang X., Park K.H., Noh S.H., Roh J.K., Chung H.C. Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients. Cancer Lett. 2010, 288:124-132.
3. Bagley R.G., Walter-Yohrling J., Cao X., Weber W., Simons B., Cook B.P., Chartrand S.D., Wang C., Madden S.L., Teicher B.A. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells. Cancer Res. 2003, 63:5866-5873.
4. Bulnes S., Argandoña E.G., Bengoetxea H., Leis O., Ortuzar N., Lafuente J.V. The role of eNOS in vascular permeability in ENU-induced gliomas. Acta Neurochir. Suppl. 2010, 106:277-282.
5. Chakraborty G., Jain S., Behera R., Ahmed M., Sharma P., Kumar V., Kundu G.C. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr. Mol. Med. 2006, 6:819-830.
6. Chakraborty G., Jain S., Kundu G.C. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 2008, 68:152-161.
7. Chen J.X., Meyrick B. Hypoxia increases Hsp90 binding to eNOS via PI3K-AKT in porcine coronary artery endothelium. Lab. Invest. 2004, 84:182-190.
8. Colla S., Morandi F., Lazzaretti M., Rizzato R., Lunghi P., Bonomini S., Mancini C., Pedrazzoni M., Crugnola M., Rizzoli V., Giuliani N. Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia 2005, 19:2166-2176.
9. Dai J., Peng L., Fan K., Wang H., Wei R., Ji G., Cai J., Lu B., Li B., Zhang D., Kang Y., Tan M., Qian W., Guo Y. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 2009, 28:3412-3422.
10. Dunn I.F., Heese O., Black P.M. Growth factors in glioma angiogenesis: FGFs, PDGF EGF, and TGFs. J. Neurooncol. 2000, 50:121-137.
11. Huang Z., Bao S.D. Roles of main pro- and anti-angiogenic factors in tumor angiogenesis. World J. Gastroenterol. 2004, 10:463-470.
12. Jouanneau E. Angiogenesis and gliomas: current issues and development of surrogate markers. Neurosurgery 2008, 62:31-50.
13. Lamszus K., Heese O., Westphal M. Angiogenesis-related growth factors in brain tumors. Cancer Treat. Res. 2004, 117:169-190.
14. Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Symes J.F., Fishman M.C., Huang P.L., Isner J.M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 1998, 101:2567-2578.
15. Rak J., Mitsuhashi Y., Bayko L., Filmus J., Shirasawa S., Sasazuki T., Kerbel R.S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 1995, 55:4575-4580.
16. Smith R.S., Lin K.F., Agata J., Chao L., Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1279-1285.
17. Saitoh Y., Kuratsu J., Takeshima H., Yamamoto S., Ushio Y. Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab. Invest. 1995, 72:55-63.
18. Matusan-Ilijas K., Behrem S., Jonjic N., Zarkovic K., Lucin K. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma. Pathol. Oncol. Res. 2008, 14:293-298.
19. Tang H., Wang J., Bai F., Hong L., Liang J., Gao J., Zhai H., Lan M., Zhang F., Wu K., Fan D. Inhibition of osteopontin would suppress angiogenesis in gastric cancer. Biochem. Cell Biol. 2007, 85:103-110.
20. Takahashi F., Akutagawa S., Fukumoto H., Tsukiyama S., Ohe Y., Takahashi K., Fukuchi Y., Saijo N., Nishio K. Osteopontin induces angiogenesis of murine neuroblastoma cells in mice. Int. J. Cancer 2002, 98:707-712.
21. Tanimoto T., Jin Z.G., Berk B.C. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of AKT and endothelial nitric-oxide synthase (eNOS). J. Biol. Chem. 2002, 277:42997-43001.
22. Wai P.Y., Kuo P.C. The role of Osteopontin in tumor metastasis. J. Surg. Res. 2004, 121:228-241.
23. Zhang J., Zhao P., Fu Z., Chen X., Liu N., Lu A., Li R., Shi L., Pu P., Kang C., You Y. Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1. Oncol. Rep. 2008, 20:1457-1463.
24. Zheng P.P., Hop W.C., Luider T.M., Sillevis Smitt P.A., Kros J.M. Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas. Ann. Neurol. 2007, 62:40-48.